Westlake Omics Closes ￥10M Seed Funding Round

(VCBeat) Mar. 1, 2021 -- Westlake Omics Biotechnology Co., Ltd. ("Westlake Omics"), which is committed to the application of proteomics in clinical assistant diagnosis, announced today that it has raised tens of millions of yuan in the seed round financing, co-led by CD Capital and Gaorong Capital, with participation from GL Ventures. The funds are earmarked for talent recruitment, technology development, clinical laboratory construction, R&D cooperation, etc.

Founded in July 2020, Westlake Omics is committed to the combination of proteomic big data and AI and the digitization of biological samples based on mass spectrometry. It is engaged in the development of new methods for clinical assistant diagnosis based on proteomics and other molecular omics, to help achieve accurate computer-assisted diagnosis of cancer and other major human diseases.

At present, Westlake Omics has built a team of professionals in proteomics, clinical medicine, AI and other interdisciplinary fields, and is fully carrying out the research of "clinical transformation and application of a new generation of protein spectrum". Through the integration of AI+ deep learning and medical big data, the team is actively exploring new diagnostic methods and therapeutic targets with potential clinical applications.

Based on the frontier technology of AI, Westlake Omics builds new models and algorithms for data analysis and mining according to the characteristics of multi-omics big data to verify targets, so as to solve a series of clinical problems. The team focuses on the accurate classification, prognosis prediction and precision treatment of major human diseases (such as tumor and metabolic diseases).

CD Capital is a venture capital firm specialized in life sciences and medical technology. It is currently managing both RMB and USD funds with a total size of $600 million. The company has made over 40 investments with high growth potential and earned a reputation as a premier venture capital firm with the main focus on the Chinese healthcare industry.

Gaorong Capital is devoted to creating a better life through innovation. It is dedicated to identifying the leading founders and collaborating with them to achieve long-term value. Gaorong Capital focuses on the investment of innovations in technology and business models along with industrial integration.